|
|
|
| United States Patent | 5154501 |
| Link to this page | http://www.wikipatents.com/5154501.html |
| Inventor(s) | Svenson; Robert H. (Charlotte, NC);
King; Wendell (North Oaks, MN) |
| Abstract | An electrophysiologically guided arrhythmia ablation system for ventricular
tachycardia or other arrhythmias. The system includes recording the
electrical activation time of various parts of the heart for locating the
active site of the arrhythmia. The system has the capability of processing
local myocardial electrical activation data. The process includes
identification of an active site which occurs during the 20-80%,
preferably 35-50%, time period of a diastolic interval. The diastolic
interval is monitored by appropriate electrical connections between the
heart and a monitor. A mapping device connects to the monitor which maps
for indicating an active site. The active site is then a site for
preferred placement of an electrode for a defibrilator. |
|
|
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 5154501 |
|
|
Process for identification of an active site of ventricular tachycardia
and for electrode attachment of an endocardial defibrilator |
|
|
|
|
|
| Publication Date |
October 13, 1992 |
|
|
|
|
|
| Filing Date |
October 19, 1990 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
Description  |
|
|
BACKGROUND OF THE INVENTION
1. Definitions
A. VT - Ventricular tachycardia.
B. Active Site Critical site to deliver ablation energy to cure VT
identified by electrical activations.
C. Diastolic - That period of time between two QRS complexes of the
electrocardiogram.
D. Ablation - The delivery of destructive energy to the cardiac tissues
containing the active site.
2. Field of the Invention
The present invention pertains to a medical system, and more particularly,
pertains to cardiac electrophysiology, specifically, ablation of cardiac
arrhythmias or modification of the electrical properties of the
myocardium. The present invention is also a process for identification of
an active site of origin of ventricular tachycardia and for electrode
attachment of an endocardial defibrilator lead.
3. Description of the Prior Art
In existing technology, the recognition of the site of the origin of the
arrhythmias and the ablation function are performed separately. For
ventricular tachycardia, there has been no consensus of opinion as to what
electrical activation times constitute the "site of origin". Furthermore,
the ablation energy source, whether DC current shock, radio frequency,
microwave, or laser, has to be separately redirected by visual means to
the site of suspected origin of the arrhythmia.
Arrhythmia ablation is currently performed during open heat surgery or
through catheters directed percutaneously through the heart. During the
surgical approach, either a hand-held electrical mapping probe or a
computerized array of electrodes acquire electrical activation data
seeking the site of origin of the arrhythmia. In the percutaneous catheter
based approach, a catheter with recording electrodes is positioned in the
heart under fluoroscopic guidance.
Following acquisition of electrical activation data, ablation energy is
then later delivered by hand-held probes or catheters either in the
operating room or in the cardiac catheterizational lab.
In the prior art, the process for identification of the "site of origin" of
the arrhythmia was performed with electrical recording procedures designed
to map the spread of electrical activation in the heart looking for the
site of earliest electrical activation (site of origin). This procedure is
carried out by sequentially moving a hand-held electrical recording probe
or catheter over the heart and recording the time of arrival of the
electrical impulse to that location. This process turned out to be a long
and tedious procedure.
Prior art mapping procedures also include a sock multiple electrode array
(epicardial), a balloon endocardial electrode array, a single hand-held
mapping probe, or a multiple electrode catheter (endocardial) inside a
chamber of the heart. These procedures require a skilled surgeon and
cardiac electrophysiologist.
The particular concern was the preferred location for an electrode for an
endocardial defibrilator. It was not an easy procedure to determine the
preferred placement at the active site.
The prior art mapping procedures are capable of reconstructing the spread
of electrical activation in the heart, but do not in themselves identify
the "active site" of the arrhythmia, can be time consuming, and are
separate functions from the prior art ablation procedures.
The present invention overcomes the disadvantages of the prior art by
recognizing a particular window or time zone of electrical activation
during the diastolic interval of the arrhythmia where ablation energy
could be delivered with a high probability for successful cure.
SUMMARY OF THE INVENTION
The general purpose of the present invention is the process for
identification of the critical site to attach an electrode for an
endocardial defibrilator to control cardiac arrhythmia. For ventricular
tachycardia, the process involves identification of a site activating
during the 20-80%, preferably 35-50% of the electrical diastolic period as
referenced to the body surface electrocardiogram. The electrode can be
either an endocardial electrode or an epicardial electrode as may be
requested.
According to one embodiment of the present invention, there is provided a
process for identification of a site or sites for attachment of an
electrode for a defibrilator of diastolic activation during ventricular
tachycardia including the steps of measuring the diastolic interval of a
heart, mapping heart tissue for an active site, identifying the active
site in the 20-80%, preferably 35-50%, time period of the diastolic
interval. The electrode can be either an endocardial electrode or an
epicardial electrode.
The system includes the electrical activation data generation means,
whether from a hand-held mapping probe or computerized electrode array in
the operating room or with an electrode catheter by percutaneous approach.
The system includes recognition of the appropriate electrical markers of
the active site. For ventricular tachycardia, the critical active site
defined in electrical activation terms encompasses a critical window of
electrical activation time within electrical diastole as viewed from the
surface ECG, i.e., 20-80%, preferably 35-50%, of the time between QRS
complexes of the arrhythmia. This critical window of activation timing has
not previously been identified.
One significant aspect and feature of the present invention is the
recognition that active sites occur during the 20-80%, preferably 35-50%,
time period of a diastolic interval.
Another significant aspect and feature of the present invention is the
recognition of a time zone of 160-50 milliseconds before the onset of a
QRS complex in which active sites occur during VT.
A further significant aspect and feature of the present invention is that a
site of origin for VT is now recognized as the active site.
Having thus described the embodiments of the present invention, it is a
principal object hereof to provide a process for identification of active
sites for attachment of an electrode for an endocardial defibrilator.
Objects of the present invention include knowledge of the active site of
ventricular tachycardia.
BRIEF DESCRIPTION OF THE DRAWINGS
Other objects of the present invention and many of the attendant advantages
of the present invention will be readily appreciated as the same becomes
better understood by reference to the following detailed description when
considered in connection with the accompanying drawings, in which like
reference numerals designate like parts throughout the figures thereof and
wherein:
FIG. 1 illustrates a system schematic of a process for identification of an
active site and attachment of an electrode for a defibrilator.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
FIG. 1 illustrates a system schematic of a process for identification of an
active site including a heart 10 of a patient 18, a monitor 12, and ECG
electrodes 14a-14d connected by a cable 16 from the patient 18 to the
monitor 12. A mapping electrode 22 for mapping of an active site or sites
also connects to the monitor 12. A display 20 is shown on the monitor 12.
A filter 24 can connect to the mapping electrode lead 22, and an
illuminating display 26 such as an LED connects to the filter to indicate
an active site. An electrical signaling device 28 can also connect to the
filter, to indicate an active site.
Active sites are indicated between the 20-80%, preferably 35-50%, time
period of the diastolic interval on the display.
Once an active site is located, the site is appropriate for placement of an
electrode for a defibrilator 34. The endocardial electrode 30 can also be
the mapping electrode, one in the same as illustrated in the box 32 in the
dashed lines for purposes of illustration only and not to be construed or
limiting of the present invention. Any suitable defibrilation can be
utilized corresponding to the appropriate type of electrode.
MODE OF OPERATION
In particular, each heart beat is displayed on monitor 12. A number of
consecutive beats is monitored to verify the stability of the electrical
recording. After the passage of one interval for which the time period
thereof is measured, a second interval begins and the appropriate window
is taken. The catheter is put in place, and the signal generated indicates
whether it is in the window or not. If in the window, activation of
ablation energy is initiated. If not in the window, the device is moved
until in the window.
The steps for the process of identification of an active site for VT and
for attachment of an electrode for a defibrilator are performed by
appropriate medical personnel in accordance with the Description of the
Preferred Embodiments. The recognition of the active sites in the
preferred 35-50% window or broadly, the 20-80% window, of the diastolic is
the present invention. The teachings of the present invention can be
utilized for either an endocardial electrode or an epicardial electrode
for a defibrilator.
Various modifications can be made to the present invention without
departing from the apparent scope hereof.
* * * * *
|
|
|
|
|
Description  |
|